Literature DB >> 16847905

Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.

Tadahiro Nozoe1, Tatsuya Rikimaru, Emiko Mori, Toshiro Okuyama, Ikuo Takahashi.   

Abstract

BACKGROUND AND OBJECTIVES: Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) are well known to be the most common tumor markers of colorectal carcinomas. However, the significance of increase in these markers to predict the prognosis of the patients remains a problem for debate.
METHODS: One hundred three patients with colorectal carcinoma, who had been treated by resection and reconstruction of digestive tracts were studied. Correlation of preoperative serum value of CEA and CA19-9 with clinicopathologic features including prognosis of the patients was investigated.
RESULTS: Preoperative elevation of both of the two markers proved to be an independent prognostic indicator, however, an elevation of only one of the two markers did not obtain a prognostic significance.
CONCLUSIONS: Combined data of preoperative increase in CEA and CA19-9 in sera can provide a powerful and useful information to predict prognosis of patients with colorectal carcinoma. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847905     DOI: 10.1002/jso.20577

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  24 in total

Review 1.  Restaging of colorectal cancer and PET/CT.

Authors:  Alev Çınar; Esra Arzu Gençoğlu; Meliha Korkmaz
Journal:  Ulus Cerrahi Derg       Date:  2013-06-01

2.  Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.

Authors:  Pei-Ching Lin; Jen-Kou Lin; Chun-Chi Lin; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Yuan-Tzu Lan; Tzu-Chen Lin; Anna Fen-Yau Li; Wei-Shone Chen; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2012-03-20       Impact factor: 2.571

3.  Log odds of positive lymph nodes is superior to the number- and ratio-based lymph node classification systems for colorectal cancer patients undergoing curative (R0) resection.

Authors:  Hong Yan Fang; Hui Yang; Zhong Shi He; Hong Zhao; Zhen Ming Fu; Fu Xiang Zhou; Yun Feng Zhou
Journal:  Mol Clin Oncol       Date:  2017-03-22

4.  Comparison between surgical outcomes of colorectal cancer in younger and elderly patients.

Authors:  Longxue Jin; Norio Inoue; Naoki Sato; Susumu Matsumoto; Hitoshi Kanno; Yuko Hashimoto; Kazuhiro Tasaki; Kinya Sato; Shun Sato; Katsutoshi Kaneko
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

5.  Multianalyte tests for the early detection of cancer: speedbumps and barriers.

Authors:  Michael A Tainsky; Madhumita Chatterjee; Nancy K Levin; Sorin Draghici; Judith Abrams
Journal:  Biomark Insights       Date:  2007-07-10

6.  The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer.

Authors:  Hyeon Yu; Gyung-Mo Son; Yong-Geul Joh
Journal:  J Korean Surg Soc       Date:  2013-03-26

7.  Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population.

Authors:  Xuejiao Hu; Lixin Li; Mengqiao Shang; Juan Zhou; Xingbo Song; Xiaojun Lu; Jun Wang; Binwu Ying; Lanlan Wang
Journal:  Tumour Biol       Date:  2013-10-18

8.  Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.

Authors:  Michele McElroy; Sharmeela Kaushal; George A Luiken; Mark A Talamini; A R Moossa; Robert M Hoffman; Michael Bouvet
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

9.  Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors.

Authors:  Chi Zhou; Hua-Shan Liu; Xuan-Hui Liu; Xiao-Bin Zheng; Tuo Hu; Zhen-Xing Liang; Xiao-Wen He; Xiao-Sheng He; Jian-Cong Hu; Xiao-Jian Wu; Xian-Rui Wu; Ping Lan
Journal:  Ann Transl Med       Date:  2019-10

10.  Colorectal carcinoma with extremely low CA19-9.

Authors:  Yutaka J Kawamura; Aika Tokumitsu; Junichi Sasaki; Shingo Tsujinaka; Takafumi Maeda; Ken Mizogami; Fumio Konishi
Journal:  Gastroenterol Res Pract       Date:  2009-08-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.